logo

Health News

Share
Smoking-hearingloss-031418.jpgA study published by Oxford University Press has found that smokers are at a greater risk of hearing loss. The study involved 50,000 participants, aged 20-64 years, who were followed up for a maximum of 8 years in Nicotine & Tobacco Research.
Read More

aphria-dec04.jpgShares of Aphria Inc. tumbled more than 23 percent in Tuesday's regular trading on the New York Stock Exchange after a short seller called the Canada-based medical cannabis company a "black hole" and alleged that the company's recent Latin American acquisitions appeared to be largely worthless. In response to the allegations, Aphria said it believes the short-seller report is malicious.
Read More
fluemen-july19.jpg Women are said to experience a more severe outcome from influenza A virus infection and recover slower than men, even when the viral load is the same in both the genders. Acupuncture-Breastcancer-012218.jpg One of the major drawback of aromatase inhibitors, a class of drugs, commonly used in the management of estrogen receptor-positive (ER+) breast cancer is the debilitating joint pain. A large clinical trial, which involved a total of 226 patients from 11 cancer centers, has found that acupuncture can significantly reduce the troublesome joint pain caused by the aromatase inhibitors. Scientists-Discussion-010318.jpg Hysterectomy, which refers to the surgical removal of a woman's uterus, is the second most common gynecologic surgery performed in the United States, next only to Caesarean Sections. Read More

Alzheimer's Tau Protein Raises Risk Of Cancer Too: Study



One of the hallmarks of Alzheimer's disease is the presence of neurofibrillary tangles inside neurons - i.e., the cells that make up the brain and the nervous system. The neurofibrillary tangles are composed of mutated Tau protein. So Tau is an attractive target for developing a new Alzheimer's therapy.
Read More
lemtrada-nov30.jpg

FDA Warns About Serious Side Effects Of Multiple Sclerosis Drug



The FDA is warning consumers about the risk of rare but serious cases of stroke and tears in the lining of arteries in the head and neck associated with multiple sclerosis drug Lemtrada, chemically known as Alemtuzumab. These problems can lead to permanent disability and even death.
Read More
adhd-july18.jpg

Frequent Use Of Digital Media Linked To ADHD Symptoms In Adolescents, Says Study



Frequent use of digital media is associated with the development of attention-deficit/hyperactivity disorder (ADHD) symptoms during adolescence, finds a new study conducted by a team of researchers of the University of Southern California.
Read More
thalidomidebabies-aug06.jpgThalidomide babies or Thalidomide disaster. Do these terms sound familiar? Understanding the mechanism of Thalidomide-induced birth defects has always been of interest to the scientific community. Now, scientists at the Dana-Farber Cancer Institute have finally found an answer.
Read More
Follow RTT


FDA Calendar
Event DateSymbolDrug NameEvent Name
02/25/19BHC, BHC.TO Loteprednol etabonate ophthalmic gel (NDA)FDA decision on Loteprednol etabonate ophthalmic gel for post-operative inflammation and pain following ocular surgery
02/18/19ALXNALXN1210 (BLA)FDA decision on ALXN1210 for the treatment of patients with paroxysmal nocturnal hemoglobinuria
02/13/19MTFBIclaprim (NDA)FDA decision on Iclaprim for acute bacterial skin and skin structure infections
02/02/19EOLSDWP-450(Resubmitted BLA)FDA decision on DWP-450 for treatment of moderate to severe glabellar lines
01/31/19ALKSALKS 5461 (NDA)FDA’s final decision on ALKS 5461 for adjunctive treatment of major depressive disorder
01/29/19AQSTAPL-130277 (NDA)FDA decision on APL-130277 to overcome episodic off periods in Parkinson's disease
View All